Frontiers | Advancing NSCLC Treatment: Overcoming Challenges in Immune Checkpoint Inhibitor Therapy

Advancing NSCLC Treatment: Overcoming Challenges in Immune Checkpoint Inhibitor Therapy

541
Total downloads
2,775
Total views and downloads

Articles

ORIGINAL RESEARCH

Accepted on 24 Jan 2025

Real-world treatment and retreatment patterns and outcomes in patients with advanced or metastatic non-small cell lung cancer following nivolumab monotherapy in second line or later in France: an I-O Optimise analysis

Gregoire Justeau
Christos Chouaid
Didier Debieuvre
Clarisse Audigier-Valette
Xavier Quantin
Herve Lena
Lise Bosquet
Nicolas Girard
Minouk J Schoemaker
6 more
Maurice Pérol

doi 10.3389/fonc.2025.1526931

CASE REPORT

Published on 23 Jan 2025

Pulmonary enteric adenocarcinoma with progression disease after second - line therapy: a case report

Ya Guo
Bin Zhang
Heng Zhang
Yunbin Gao
Haibo Zhao
Pei Jiang
Qing-Qing Yu

doi 10.3389/fonc.2025.1509026

113 views

ORIGINAL RESEARCH

Published on 23 Jan 2025

The effect of baseline versus early glucocorticoid use on immune checkpoint inhibitor efficacy in patients with advanced NSCLC

Yifan Wang
Jianying Zhou
Simin Peng
Zhao Cui
Weiqi Wang
Wenqin Zeng
Tingting Qiu
Zhentian Liu

doi 10.3389/fonc.2025.1533556

233 views

CASE REPORT

Published on 11 Oct 2024

Management of overlapping immune-related myocarditis, myositis, and myasthenia in a young patient with advanced NSCLC: a case report

Monica Mariniello
Giulia Arrivi
Laura Tufano
Antonio Lauletta
Mirella Moro
Giacomo Tini
Matteo Garibaldi
Raffaele Giusti
Federica Mazzuca

doi 10.3389/fonc.2024.1431971

1,048 views
1 citation

Share on

Frontiers in Pharmacology

Frontiers in Pharmacology

Pharmacology of Anti-Cancer Drugs

Participating Journals

Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- 3.5 impact factor
- 6.2 citescore

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

2,775Topic views
1,289Article views
541Article downloads